vs
Side-by-side financial comparison of Dexcom (DXCM) and ZIONS BANCORPORATION, NATIONAL ASSOCIATION (ZION). Click either name above to swap in a different company.
Dexcom is the larger business by last-quarter revenue ($1.3B vs $891.0M, roughly 1.4× ZIONS BANCORPORATION, NATIONAL ASSOCIATION). ZIONS BANCORPORATION, NATIONAL ASSOCIATION runs the higher net margin — 29.5% vs 21.2%, a 8.3% gap on every dollar of revenue. On growth, Dexcom posted the faster year-over-year revenue change (21.6% vs 8.7%). Over the past eight quarters, Dexcom's revenue compounded faster (12.0% CAGR vs 9.6%).
Dexcom, Inc. is an American multinational healthcare company that develops, manufactures, produces and distributes a line of continuous glucose monitoring (CGM) systems for diabetes management. It operates internationally with global headquarters and R&D center in San Diego, California, U.S.A. and manufacturing facilities in Mesa, Arizona, U.S.A.; Batu Kawan, Malaysia and Athenry, County Galway, Ireland.
Zions Bancorporation is an American national bank headquartered in Salt Lake City, Utah. It operates as a national bank rather than as a bank holding company and does business under the following seven brands: Zions Bank, Amegy Bank of Texas, California Bank and Trust, National Bank of Arizona, Nevada State Bank, Vectra Bank Colorado, and the Commerce Bank of Washington.
DXCM vs ZION — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.3B | $891.0M |
| Net Profit | $267.3M | $263.0M |
| Gross Margin | 62.9% | — |
| Operating Margin | 25.6% | — |
| Net Margin | 21.2% | 29.5% |
| Revenue YoY | 21.6% | 8.7% |
| Net Profit YoY | 153.6% | 21.8% |
| EPS (diluted) | $0.67 | $1.77 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $1.3B | — | ||
| Q4 25 | $1.3B | $891.0M | ||
| Q3 25 | $1.2B | $861.0M | ||
| Q2 25 | $1.2B | $838.0M | ||
| Q1 25 | $1.0B | $795.0M | ||
| Q4 24 | $1.1B | $820.0M | ||
| Q3 24 | $994.2M | $792.0M | ||
| Q2 24 | $1.0B | $777.0M |
| Q1 26 | $267.3M | — | ||
| Q4 25 | $267.3M | $263.0M | ||
| Q3 25 | $283.8M | $222.0M | ||
| Q2 25 | $179.8M | $244.0M | ||
| Q1 25 | $105.4M | $170.0M | ||
| Q4 24 | $151.7M | $216.0M | ||
| Q3 24 | $134.6M | $214.0M | ||
| Q2 24 | $143.5M | $201.0M |
| Q1 26 | 62.9% | — | ||
| Q4 25 | 62.9% | — | ||
| Q3 25 | 60.5% | — | ||
| Q2 25 | 59.5% | — | ||
| Q1 25 | 56.9% | — | ||
| Q4 24 | 58.9% | — | ||
| Q3 24 | 59.7% | — | ||
| Q2 24 | 62.4% | — |
| Q1 26 | 25.6% | — | ||
| Q4 25 | 25.6% | — | ||
| Q3 25 | 20.1% | — | ||
| Q2 25 | 18.4% | — | ||
| Q1 25 | 12.9% | — | ||
| Q4 24 | 17.0% | — | ||
| Q3 24 | 15.3% | — | ||
| Q2 24 | 15.7% | — |
| Q1 26 | 21.2% | — | ||
| Q4 25 | 21.2% | 29.5% | ||
| Q3 25 | 23.5% | 25.8% | ||
| Q2 25 | 15.5% | 29.1% | ||
| Q1 25 | 10.2% | 21.4% | ||
| Q4 24 | 13.6% | 26.3% | ||
| Q3 24 | 13.5% | 27.0% | ||
| Q2 24 | 14.3% | 25.9% |
| Q1 26 | $0.67 | — | ||
| Q4 25 | $0.67 | $1.77 | ||
| Q3 25 | $0.70 | $1.48 | ||
| Q2 25 | $0.45 | $1.63 | ||
| Q1 25 | $0.27 | $1.13 | ||
| Q4 24 | $0.37 | $1.34 | ||
| Q3 24 | $0.34 | $1.37 | ||
| Q2 24 | $0.35 | $1.28 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $917.7M | — |
| Total DebtLower is stronger | — | $1.5B |
| Stockholders' EquityBook value | $2.7B | $7.2B |
| Total Assets | $6.3B | $89.0B |
| Debt / EquityLower = less leverage | — | 0.21× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $917.7M | — | ||
| Q4 25 | $917.7M | — | ||
| Q3 25 | $1.8B | — | ||
| Q2 25 | $1.2B | — | ||
| Q1 25 | $904.9M | — | ||
| Q4 24 | $606.1M | — | ||
| Q3 24 | $621.2M | — | ||
| Q2 24 | $939.2M | — |
| Q1 26 | — | — | ||
| Q4 25 | — | $1.5B | ||
| Q3 25 | — | $1.5B | ||
| Q2 25 | — | $970.0M | ||
| Q1 25 | — | $964.0M | ||
| Q4 24 | — | $950.0M | ||
| Q3 24 | — | $548.0M | ||
| Q2 24 | — | $546.0M |
| Q1 26 | $2.7B | — | ||
| Q4 25 | $2.7B | $7.2B | ||
| Q3 25 | $2.7B | $6.9B | ||
| Q2 25 | $2.6B | $6.6B | ||
| Q1 25 | $2.3B | $6.3B | ||
| Q4 24 | $2.1B | $6.1B | ||
| Q3 24 | $2.0B | $6.4B | ||
| Q2 24 | $2.4B | $6.0B |
| Q1 26 | $6.3B | — | ||
| Q4 25 | $6.3B | $89.0B | ||
| Q3 25 | $7.5B | $88.5B | ||
| Q2 25 | $7.3B | $88.9B | ||
| Q1 25 | $6.8B | $88.0B | ||
| Q4 24 | $6.5B | $88.8B | ||
| Q3 24 | $6.4B | $87.0B | ||
| Q2 24 | $6.8B | $87.6B |
| Q1 26 | — | — | ||
| Q4 25 | — | 0.21× | ||
| Q3 25 | — | 0.21× | ||
| Q2 25 | — | 0.15× | ||
| Q1 25 | — | 0.15× | ||
| Q4 24 | — | 0.16× | ||
| Q3 24 | — | 0.09× | ||
| Q2 24 | — | 0.09× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $1.1B |
| Free Cash FlowOCF − Capex | — | $952.0M |
| FCF MarginFCF / Revenue | — | 106.8% |
| Capex IntensityCapex / Revenue | — | 13.6% |
| Cash ConversionOCF / Net Profit | — | 4.08× |
| TTM Free Cash FlowTrailing 4 quarters | — | $1.4B |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $294.0M | $1.1B | ||
| Q3 25 | $659.9M | $438.0M | ||
| Q2 25 | $303.0M | $-62.0M | ||
| Q1 25 | $183.8M | $179.0M | ||
| Q4 24 | $301.4M | $1.1B | ||
| Q3 24 | $199.5M | $119.0M | ||
| Q2 24 | $279.4M | $251.0M |
| Q1 26 | — | — | ||
| Q4 25 | $192.1M | $952.0M | ||
| Q3 25 | $579.4M | $413.0M | ||
| Q2 25 | $208.9M | $-93.0M | ||
| Q1 25 | $96.8M | $152.0M | ||
| Q4 24 | $176.8M | $1.1B | ||
| Q3 24 | $88.3M | $97.0M | ||
| Q2 24 | $213.3M | $234.0M |
| Q1 26 | — | — | ||
| Q4 25 | 15.3% | 106.8% | ||
| Q3 25 | 47.9% | 48.0% | ||
| Q2 25 | 18.1% | -11.1% | ||
| Q1 25 | 9.3% | 19.1% | ||
| Q4 24 | 15.9% | 128.2% | ||
| Q3 24 | 8.9% | 12.2% | ||
| Q2 24 | 21.2% | 30.1% |
| Q1 26 | — | — | ||
| Q4 25 | 8.1% | 13.6% | ||
| Q3 25 | 6.7% | 2.9% | ||
| Q2 25 | 8.1% | 3.7% | ||
| Q1 25 | 8.4% | 3.4% | ||
| Q4 24 | 11.2% | 11.8% | ||
| Q3 24 | 11.2% | 2.8% | ||
| Q2 24 | 6.6% | 2.2% |
| Q1 26 | — | — | ||
| Q4 25 | 1.10× | 4.08× | ||
| Q3 25 | 2.33× | 1.97× | ||
| Q2 25 | 1.69× | -0.25× | ||
| Q1 25 | 1.74× | 1.05× | ||
| Q4 24 | 1.99× | 5.31× | ||
| Q3 24 | 1.48× | 0.56× | ||
| Q2 24 | 1.95× | 1.25× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
